Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here
X

Keytruda improves survival in late-stage trial of cHL

KEYTRUDA_0203
FDA approved Keytruda to treat refractory cHL in March 2017. Credit: Merck Sharp & Dohme Corp.